Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 34, Pages e2106612118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-08-18
DOI
10.1073/pnas.2106612118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
- (2021) Max Jan et al. Science Translational Medicine
- T cell circuits that sense antigen density with an ultrasensitive threshold
- (2021) Rogelio A. Hernandez-Lopez et al. SCIENCE
- Circularly permuted LOV2 as a modular photoswitch for optogenetic engineering
- (2021) Lian He et al. Nature Chemical Biology
- Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
- (2021) Evan W. Weber et al. SCIENCE
- SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models
- (2021) Axel Hyrenius-Wittsten et al. Science Translational Medicine
- SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
- (2021) Joseph H. Choe et al. Science Translational Medicine
- A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
- (2020) Greta Giordano-Attianese et al. NATURE BIOTECHNOLOGY
- Engineering light-controllable CAR T cells for cancer immunotherapy
- (2020) Ziliang Huang et al. Science Advances
- Precise T cell recognition programs designed by transcriptionally linking multiple receptors
- (2020) Jasper Z. Williams et al. SCIENCE
- Mechanisms of resistance to CAR T cell therapy
- (2019) Nirali N. Shah et al. Nature Reviews Clinical Oncology
- The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
- (2019) Katrin Mestermann et al. Science Translational Medicine
- Selective activation of TWIK-related acid-sensitive K+ 3 subunit–containing channels is analgesic in rodent models
- (2019) Ping Liao et al. Science Translational Medicine
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Synthetic Biology: Immunotherapy by Design
- (2018) Matthew J. Brenner et al. Annual Review of Biomedical Engineering
- The functional genomic studies of resveratrol in respect to its anti-cancer effects
- (2018) Lukasz Huminiecki et al. BIOTECHNOLOGY ADVANCES
- Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
- (2018) Jang Hwan Cho et al. CELL
- Immunomimetic Designer Cells Protect Mice from MRSA Infection
- (2018) Ying Liu et al. CELL
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- Designing cell function: assembly of synthetic gene circuits for cell biology applications
- (2018) Mingqi Xie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanogenetics for the remote and noninvasive control of cancer immunotherapy
- (2018) Yijia Pan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory
- (2018) Sophie Viaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Health Effects of Resveratrol: Results from Human Intervention Trials
- (2018) Sonia Ramírez-Garza et al. Nutrients
- Evidence of a DHA Signature in the Lipidome and Metabolome of Human Hepatocytes
- (2017) Veronica Ghini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib
- (2017) Cameron J. Turtle et al. JOURNAL OF CLINICAL ONCOLOGY
- Improving key enzyme activity in phenylpropanoid pathway with a designed biosensor
- (2017) Dandan Xiong et al. METABOLIC ENGINEERING
- A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes
- (2017) Shuai Xue et al. MOLECULAR THERAPY
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Control of potassium homeostasis is an essential function of the second messenger cyclic di-AMP inBacillus subtilis
- (2017) Jan Gundlach et al. Science Signaling
- Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies
- (2017) Mattia Bonsignori et al. Science Translational Medicine
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
- (2017) Juliane Gust et al. Cancer Discovery
- Control of potassium homeostasis is an essential function of the second messenger cyclic di-AMP inBacillus subtilis
- (2017) Jan Gundlach et al. Science Signaling
- CRISPR/Cas9 for Human Genome Engineering and Disease Research
- (2016) Xin Xiong et al. Annual Review of Genomics and Human Genetics
- Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
- (2016) Kole T. Roybal et al. CELL
- Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
- (2016) David T. Rodgers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- -cell-mimetic designer cells provide closed-loop glycemic control
- (2016) M. Xie et al. SCIENCE
- Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells
- (2016) Cameron J. Turtle et al. Science Translational Medicine
- Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms
- (2016) Dona Sinha et al. SEMINARS IN CANCER BIOLOGY
- A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration
- (2016) R. Sakemura et al. Cancer Immunology Research
- Self-adjusting synthetic gene circuit for correcting insulin resistance
- (2016) Haifeng Ye et al. Nature Biomedical Engineering
- Resveratrol supplementation: Where are we now and where should we go?
- (2015) Marta G. Novelle et al. AGEING RESEARCH REVIEWS
- Resveratrol regulates naïve CD 8+T-cell proliferation by upregulating IFN-γ-induced tryptophanyl-tRNA synthetase expression
- (2015) Kyung Tae Noh et al. BMB Reports
- Highly efficient Cas9-mediated transcriptional programming
- (2015) Alejandro Chavez et al. NATURE METHODS
- Molecular Binding Mechanism of TtgR Repressor to Antibiotics and Antimicrobials
- (2015) Ana Maria Fernandez-Escamilla et al. PLoS One
- Remote control of therapeutic T cells through a small molecule-gated chimeric receptor
- (2015) C.-Y. Wu et al. SCIENCE
- A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy
- (2014) B. Philip et al. BLOOD
- Resveratrol and cancer: focus on in vivo evidence
- (2014) Lindsay G Carter et al. ENDOCRINE-RELATED CANCER
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
- (2011) X. Wang et al. BLOOD
- Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
- (2011) Antonio Di Stasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthetic Biology Moving into the Clinic
- (2011) W. C. Ruder et al. SCIENCE
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
- (2010) J. N. Kochenderfer et al. BLOOD
- Domain Cross-talk during Effector Binding to the Multidrug Binding TTGR Regulator
- (2010) Craig Daniels et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Isolation of Mouse Peritoneal Cavity Cells
- (2010) Avijit Ray et al. Jove-Journal of Visualized Experiments
- Lentiviral Vector Design for Optimal T Cell Receptor Gene Expression in the Transduction of Peripheral Blood Lymphocytes and Tumor-Infiltrating Lymphocytes
- (2009) Stephanie Jones et al. HUMAN GENE THERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started